PDE9A, PDE10A, and PDE11A expression in rat trigeminovascular pain signalling system

Brain Research

Volumn 1281, Issue , 2009, Pages 25-34

  Kruse, Lars S ^a   Møller, Morten ^b   Tibæk, Maiken ^a   Gammeltoft, Steen ^a   Olesen, Jes ^a   Kruuse, Christina ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Brain; Neurovascular coupling; Phosphodiesterase; Trigeminal signalling

Indexed keywords

MESSENGER RNA; PHOSPHODIESTERASE; PHOSPHODIESTERASE 10A; PHOSPHODIESTERASE 11A; PHOSPHODIESTERASE 9A; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; BRAIN ARTERY; CEREBELLUM CORTEX; CONTROLLED STUDY; DURA MATER; IMMUNOHISTOCHEMISTRY; MALE; MENINX; MIGRAINE; NEOCORTEX; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TRIGEMINAL NUCLEUS; TRIGEMINOVASCULAR PAIN; TRIGEMINUS GANGLION; WESTERN BLOTTING;

3',5'-CYCLIC-AMP PHOSPHODIESTERASES; ANIMALS; AORTA; BLOTTING, WESTERN; BRAIN; CEREBRAL ARTERIES; DURA MATER; IMMUNOHISTOCHEMISTRY; MALE; MESENTERIC ARTERIES; MIGRAINE DISORDERS; NEURONS; PAIN; PHOSPHORIC DIESTER HYDROLASES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRIGEMINAL GANGLION; TRIGEMINAL NUCLEI; TRIGEMINAL NUCLEUS, SPINAL;

RATTUS;

EID: 67649387950     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.05.012     Document Type: Article

References (43)

1. Andreeva S.G., Dikkes P., Epstein P.M., and Rosenberg P.A. Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain. J. Neurosci. 21 (2001) 9068-9076
2. Bender A.T., and Beavo J.A. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol. Rev. 58 (2006) 488-520
3. Birk S., Kruuse C., Petersen K.A., Jonassen O., Tfelt-Hansen P., and Olesen J. The phosphodiesterase 3 inhibitor cilostazol dilates large cerebral arteries in humans without affecting regional cerebral blood flow. J. Cereb. Blood Flow Metab. 24 (2004) 1352-1358
4. Birk S., Kruuse C., Petersen K.A., Tfelt-Hansen P., and Olesen J. The headache-inducing effect of cilostazol in human volunteers. Cephalalgia 26 (2006) 1304-1309
5. Boswell-Smith V., Spina D., and Page C.P. Phosphodiesterase inhibitors. Br. J. Pharmacol. 147 Suppl 1 (2006) S252-S257
6. Buzzi M.G., and Moskowitz M.A. The pathophysiology of migraine: year 2005. J. Headache Pain 6 (2005) 105-111
7. Coskran T.M., Morton D., Menniti F.S., Adamowicz W.O., Kleiman R.J., Ryan A.M., Strick C.A., Schmidt C.J., and Stephenson D.T. Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species. J. Histochem. Cytochem. 54 (2006) 1205-1213
8. D'Andrea M.R., Qiu Y., Haynes-Johnson D., Bhattacharjee S., Kraft P., and Lundeen S. Expression of PDE11A in normal and malignant human tissues. J. Histochem. Cytochem. 53 (2005) 895-903
9. Edvinsson L., and Uddman R. Neurobiology in primary headaches. Brain Res. Brain Res. Rev. 48 (2005) 438-456
10. Fawcett L., Baxendale R., Stacey P., McGrouther C., Harrow I., Soderling S., Hetman J., Beavo J.A., and Phillips S.C. Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 3702-3707
11. Fisher D.A., Smith J.F., Pillar J.S., St Denis S.H., and Cheng J.B. Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J. Biol. Chem. 273 (1998) 15559-15564
12. Fujishige K., Kotera J., Michibata H., Yuasa K., Takebayashi S., Okumura K., and Omori K. Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A). J. Biol. Chem. 274 (1999) 18438-18445
13. Fujishige K., Kotera J., and Omori K. Striatum- and testis-specific phosphodiesterase PDE10A isolation and characterization of a rat PDE10A. Eur. J. Biochem. 266 (1999) 1118-1127
14. Goadsby P.J. Migraine pathophysiology. Headache 45 Suppl 1 (2005) S14-S24
15. Gross-Langenhoff M., Hofbauer K., Weber J., Schultz A., and Schultz J.E. cAMP is a ligand for the tandem GAF domain of human phosphodiesterase 10 and cGMP for the tandem GAF domain of phosphodiesterase 11. J. Biol. Chem. 281 (2006) 2841-2846
16. Guipponi M., Scott H.S., Kudoh J., Kawasaki K., Shibuya K., Shintani A., Asakawa S., Chen H., Lalioti M.D., Rossier C., Minoshima S., Shimizu N., and Antonarakis S.E. Identification and characterization of a novel cyclic nucleotide phosphodiesterase gene (PDE9A) that maps to 21q22.3: alternative splicing of mRNA transcripts, genomic structure and sequence. Hum. Genet. 103 (1998) 386-392
17. Hebb A.L., and Robertson H.A. Role of phosphodiesterases in neurological and psychiatric disease. Curr. Opin. Pharmacol. 7 (2007) 86-92
18. Hebb A.L., Robertson H.A., and Denovan-Wright E.M. Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms. Neuroscience 123 (2004) 967-981
19. Hetman J.M., Robas N., Baxendale R., Fidock M., Phillips S.C., Soderling S.H., and Beavo J.A. Cloning and characterization of two splice variants of human phosphodiesterase 11A. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 12891-12895
20. Hu H., McCaw E.A., Hebb A.L., Gomez G.T., and Denovan-Wright E.M. Mutant huntingtin affects the rate of transcription of striatum-specific isoforms of phosphodiesterase 10A. Eur. J. Neurosci. 20 (2004) 3351-3363
21. Kotera J., Fujishige K., Yuasa K., and Omori K. Characterization and phosphorylation of PDE10A2, a novel alternative splice variant of human phosphodiesterase that hydrolyzes cAMP and cGMP. Biochem. Biophys. Res. Commun. 261 (1999) 551-557
22. Kotera J., Sasaki T., Kobayashi T., Fujishige K., Yamashita Y., and Omori K. Subcellular localization of cyclic nucleotide phosphodiesterase type 10A variants, and alteration of the localization by cAMP-dependent protein kinase-dependent phosphorylation. J. Biol. Chem. 279 (2004) 4366-4375
23. Kruuse C., Rybalkin S.D., Khurana T.S., Jansen-Olesen I., Olesen J., and Edvinsson L. The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation. Eur. J. Pharmacol. 420 (2001) 55-65
24. Kruuse C., Thomsen L.L., Jacobsen T.B., and Olesen J. The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects. J. Cereb. Blood Flow Metab. 22 (2002) 1124-1131
25. Kruuse C., Thomsen L.L., Birk S., and Olesen J. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain 126 (2003) 241-247
26. Kruuse C., Lassen L.H., Iversen H.K., Oestergaard S., and Olesen J. Dipyridamole may induce migraine in patients with migraine without aura. Cephalalgia 26 (2006) 925-933
27. Loughney K., Taylor J., and Florio V.A. 3′,5′-cyclic nucleotide phosphodiesterase 11A: localization in human tissues. Int. J. Impot. Res. 17 (2005) 320-325
28. Martinez S.E., Beavo J.A., and Hol W.G. GAF domains: two-billion-year-old molecular switches that bind cyclic nucleotides. Mol. Interv. 2 (2002) 317-323
29. May A., and Goadsby P.J. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J. Cereb. Blood Flow Metab. 19 (1999) 115-127
30. Menniti F.S., Chappie T.A., Humphrey J.M., and Schmidt C.J. Phosphodiesterase 10A inhibitors: a novel approach to the treatment of the symptoms of schizophrenia. Curr. Opin. Investig. Drugs 8 (2007) 54-59
31. Olesen J., Thomsen L.L., Lassen L.H., and Olesen I.J. The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia 15 (1995) 94-100
32. Pelligrino D.A., and Wang Q. Cyclic nucleotide crosstalk and the regulation of cerebral vasodilation. Prog. Neurobiol. 56 (1998) 1-18
33. Pietrobon D., and Striessnig J. Neurobiology of migraine. Nat. Rev., Neurosci. 4 (2003) 386-398
34. Ray B.S., and Wolff H.G. Experimental studies on headache. Arch. Surg. 41 (1940) 813-855
35. Rentero C., Monfort A., and Puigdomenech P. Identification and distribution of different mRNA variants produced by differential splicing in the human phosphodiesterase 9A gene. Biochem. Biophys. Res. Commun. 301 (2003) 686-692
36. Seeger T.F., Bartlett B., Coskran T.M., Culp J.S., James L.C., Krull D.L., Lanfear J., Ryan A.M., Schmidt C.J., Strick C.A., Varghese A.H., Williams R.D., Wylie P.G., and Menniti F.S. Immunohistochemical localization of PDE10A in the rat brain. Brain Res. 985 (2003) 113-126
37. Soderling S.H., Bayuga S.J., and Beavo J.A. Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 7071-7076
38. van Staveren W.C., Glick J., Markerink-van Ittersum M., Shimizu M., Beavo J.A., Steinbusch H.W., and de Vente J. Cloning and localization of the cGMP-specific phosphodiesterase type 9 in the rat brain. J. Neurocytol. 31 (2002) 729-741
39. van Staveren W.C., Steinbusch H.W., Markerink-van Ittersum M., Behrends S., and de Vente J. Species differences in the localization of cGMP-producing and NO-responsive elements in the mouse and rat hippocampus using cGMP immunocytochemistry. Eur. J. Neurosci. 19 (2004) 2155-2168
40. Wang P., Wu P., Egan R.W., and Billah M.M. Identification and characterization of a new human type 9 cGMP-specific phosphodiesterase splice variant (PDE9A5). Differential tissue distribution and subcellular localization of PDE9A variants. Gene 314 (2003) 15-27
41. Xie Z., Adamowicz W.O., Eldred W.D., Jakowski A.B., Kleiman R.J., Morton D.G., Stephenson D.T., Strick C.A., Williams R.D., and Menniti F.S. Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase. Neuroscience 139 (2006) 597-607
42. Yuasa K., Kotera J., Fujishige K., Michibata H., Sasaki T., and Omori K. Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression. J. Biol. Chem. 275 (2000) 31469-31479
43. Yuasa K., Ohgaru T., Asahina M., and Omori K. Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A): comparison of rat and human PDE11A splicing variants. Eur. J. Biochem. 268 (2001) 4440-4448